Scilex Holding (SCLX) EBT (QoQ) (2020 - 2026)
Scilex Holding (SCLX) EBT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.97% |
| Dec 31, 2025 | 82.12% |
| Sep 30, 2025 | -485.57% |
| Jun 30, 2025 | -68.82% |
| Mar 31, 2025 | -303.65% |
| Dec 31, 2024 | -47.24% |
| Sep 30, 2024 | 88.32% |
| Jun 30, 2024 | -54.17% |
| Mar 31, 2024 | -13.95% |
| Dec 31, 2023 | 39.79% |
| Sep 30, 2023 | -33.31% |
| Jun 30, 2023 | 13.31% |
| Mar 31, 2023 | -72.30% |
| Dec 31, 2022 | -183.03% |
| Sep 30, 2022 | 220.28% |
| Jun 30, 2022 | -95.47% |
| Mar 31, 2022 | 80.52% |
| Dec 31, 2021 | -16,567.84% |
| Sep 30, 2021 | -70.28% |
| Jun 30, 2021 | 15.52% |